Good news! It appears there is finally some progress being made with new medications. I recently blogged here more critical about the hype of new obesity medications, but this was partially mistaken.
"As a growing number of overweight Americans clamor for Ozempic and Wegovy ... an even more powerful obesity medicine is poised to upend treatment.
Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday. ...
The late-stage study of the drug for weight loss adds to earlier evidence that similar participants without diabetes lost up to 22% of their body weight over that period with weekly injections of the drug. For a typical patient on the highest dose, that meant shedding more than 50 pounds.
Having diabetes makes it notoriously difficult to lose weight ... which means the recent results are especially significant. “We have not seen this degree of weight reduction,” ..."
No comments:
Post a Comment